Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$200M |
| 2 |
Danaher
DHR
|
+$146M |
| 3 |
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
|
+$138M |
| 4 |
Procter & Gamble
PG
|
+$122M |
| 5 |
RDS.B
Royal Dutch Shell PLC ADS Class B
RDS.B
|
+$109M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.89B |
| 2 |
Microsoft
MSFT
|
+$380M |
| 3 |
Alibaba
BABA
|
+$352M |
| 4 |
Wells Fargo
WFC
|
+$245M |
| 5 |
American Electric Power
AEP
|
+$243M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 11.41% |
| 2 | Technology | 7.27% |
| 3 | Financials | 6.46% |
| 4 | Consumer Discretionary | 5.3% |
| 5 | Industrials | 4.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ACOR
3376
DELISTED
Acorda Therapeutics
ACOR
| $184K | ﹤0.01% |
1,641
+1,466
| +838% | +$289K |
|
|
OPGN
3377
DELISTED
OpGen, Inc
OPGN
| $183K | ﹤0.01% |
358
-173
| -33% | -$72.3K |
|
3378
Alpha Pro Tech
APT
$50.4M
| $182K | ﹤0.01% |
+15,072
| New | +$126K |
|
3379
Brixmor Property Group
BRX
$9.68B
| $182K | ﹤0.01% |
+19,181
| New | +$344K |
|
|
MN
3380
DELISTED
MANNING & NAPIER, INC.
MN
| $182K | ﹤0.01% |
145,396
-6,383
| -4% | -$10.7K |
|
3381
Unum
UNM
$14.3B
| $181K | ﹤0.01% |
12,055
-268,961
| -96% | -$6.47M |
|
|
SWI
3382
DELISTED
SolarWinds Corporation Common Stock
SWI
| $181K | ﹤0.01% |
10,926
-27,451
| -72% | -$507K |
|
3383
LCNB Corp
LCNB
$282M
| $180K | ﹤0.01% |
+14,281
| New | +$235K |
|
|
MESO
3384
Mesoblast
MESO
$1.88B
| $179K | ﹤0.01% |
+20,405
| New | +$313K |
|
3385
CALL
Deutsche Bank
DB
$69.8B
| $178K | ﹤0.01% |
+27,700
| New | +$230K |
|
|
UBX
3386
DELISTED
Unity Biotechnology
UBX
| $178K | ﹤0.01% |
3,077
-36,857
| -92% | -$2.32M |
|
|
VCNX
3387
DELISTED
Vaccinex, Inc. Common Stock
VCNX
| $178K | ﹤0.01% |
212
-57
| -21% | -$64.6K |
|
3388
Babcock & Wilcox
BW
$1.42B
| $177K | ﹤0.01% |
173,441
+162,209
| +1,444% | +$585K |
|
3389
PUT
TripAdvisor
TRIP
$1.69B
| $174K | ﹤0.01% |
+10,000
| New | +$253K |
|
|
ARR
3390
Armour Residential REIT
ARR
$2.31B
| $173K | ﹤0.01% |
+3,930
| New | +$336K |
|
3391
Genesco
GCO
$435M
| $173K | ﹤0.01% |
12,969
-46,746
| -78% | -$1.58M |
|
|
RDUS
3392
DELISTED
Radius Recycling
RDUS
| $173K | ﹤0.01% |
13,236
-680,516
| -98% | -$11.4M |
|
|
IEA
3393
DELISTED
Infrastructure and Energy Alternatives, Inc. Common Stock
IEA
| $172K | ﹤0.01% |
85,359
-14,468
| -14% | -$43.3K |
|
|
NWHM
3394
DELISTED
THE NEW HOME COMPANY INC.
NWHM
| $172K | ﹤0.01% |
125,453
-1,223
| -1% | -$5.31K |
|
3395
South Plains Financial
SPFI
$840M
| $171K | ﹤0.01% |
11,050
-92,959
| -89% | -$1.78M |
|
|
DMS
3396
DELISTED
Digital Media Solutions, Inc.
DMS
| $171K | ﹤0.01% |
1,109
-44,691
| -98% | -$6.95M |
|
|
RLH
3397
DELISTED
Red Lions Hotel Corporation
RLH
| $170K | ﹤0.01% |
116,380
+28,914
| +33% | +$77.4K |
|
|
ITI
3398
DELISTED
Iteris, Inc.
ITI
| $169K | ﹤0.01% |
52,724
-40,214
| -43% | -$188K |
|
3399
Avalo Therapeutics
AVTX
$955M
| $168K | ﹤0.01% |
+24
| New | +$254K |
|
|
NID
3400
DELISTED
NUVEEN INTERMEDIATE DURATION MUNICIPAL TERM FUND
NID
| $168K | ﹤0.01% |
+12,926
| New | +$178K |
|
Similar funds
Millennium Management's Q1 2020 Portfolio in Review
As of Q1 2020, Millennium Management held 4,928 positions worth $44.5B, down 44% from $79.9B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Millennium Management withdrew a net $21.4B in Q1 2020, closing 1,154 positions and reducing 1,745 holdings. Its most notable exit was Becton Dickinson, an estimated $152M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 11% of assets, up from 9.7% a quarter earlier, followed by Technology and Financials.
Against the trend, Millennium Management opened a new position in Danaher worth $133M.
- Millennium Management's largest Q1 2020 buy was Danaher: 1,082,448 shares worth $133M.
- Millennium Management added most to Allergan plc in Q1 2020, an estimated $200M increase.
- Millennium Management's biggest Q1 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $3.89B.
- Millennium Management fully exited Becton Dickinson in Q1 2020, selling an estimated $152M.
- Millennium Management's ten largest holdings make up 18% of its $44.5B portfolio in Q1 2020.
- Millennium Management opened 789 new positions and closed 1,154 in Q1 2020.
- Millennium Management's portfolio value fell 44% quarter-over-quarter to $44.5B.
Based on Millennium Management's 13F filing for Q1 2020, filed 14 May 2020.